Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:17 pm Sale | 2024-09-30 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 40,000 1.900% | -133,913 (-77.00%) | Filing History |
| 2024-11-14 12:16 pm Unchanged | 2024-09-30 | 13G | Vision Marine Technologies Inc. VMAR | CVI Investments, Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-10-02 10:53 am Purchase | 2024-09-27 | 13G | Theriva Biologics, Inc. TOVX | CVI Investments, Inc. | 232,237 9.900% | 232,237 (New Position) | Filing History |
| 2024-09-18 10:21 am Purchase | 2024-09-13 | 13G | Vision Marine Technologies Inc. VMAR | CVI Investments, Inc. | 4,611 8.400% | 4,611 (New Position) | Filing History |
| 2024-09-16 10:22 am Purchase | 2024-09-11 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 173,913 8.500% | 173,913 (New Position) | Filing History |
| 2024-08-05 11:53 am Purchase | 2024-07-30 | 13G | Imunon, Inc. IMNN | CVI Investments, Inc. | 1,220,000 8.500% | 1,220,000 (New Position) | Filing History |
| 2024-08-01 10:26 am Purchase | 2024-07-24 | 13G | Azitra, Inc. AZTR | CVI Investments, Inc. | 610,000 8.000% | 610,000 (New Position) | Filing History |
| 2024-04-09 10:43 am Purchase | 2024-04-05 | 13G | Protara Therapeutics, Inc. TARA | CVI Investments, Inc. | 600,380 5.300% | 600,380 (New Position) | Filing History |
| 2024-04-04 10:15 am Purchase | 2024-03-28 | 13G | RENALYTIX PLC ADS RNLXY | CVI Investments, Inc. | 8,547,788 6.900% | 8,547,788 (New Position) | Filing History |
| 2024-02-16 11:28 am Purchase | 2024-02-08 | 13G | Tenax Therapeutics, Inc. TENX | CVI Investments, Inc. | 204,027 9.900% | 204,027 (New Position) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | Evofem Biosciences, Inc. EVFM | CVI Investments, Inc. | 102,799 0.900% | 102,799 (New Position) | Filing History |
| 2024-02-14 2:14 pm Unchanged | 2023-12-31 | 13G | Sidus Space, Inc. SIDU | CVI Investments, Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:14 pm Unchanged | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | CVI Investments, Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | Bitfarms Ltd. BITF | CVI Investments, Inc. | 9,259,260 2.800% | -9,259,260 (-50.00%) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | Enservco Corporation ENSV | CVI Investments, Inc. | 1,411,740 4.900% | 411,740 (+41.17%) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | CVI Investments, Inc. | 0 0.000% | -5,500,000 (Position Closed) | Filing History |
| 2024-02-14 2:14 pm Unchanged | 2023-12-31 | 13G | DUET Acquisition Corp. DUET | CVI Investments, Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | Aditxt, Inc. ADTX | CVI Investments, Inc. | 0 0.500% | 0 (New Position) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | Ryvyl Inc. RVYL | CVI Investments, Inc. | 596,135 9.900% | 596,135 (New Position) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | Nova LifeStyle, Inc. NVFY | CVI Investments, Inc. | 74,300 4.300% | 74,300 (New Position) | Filing History |